Skip to main content
PMC home page
The AAPS Journal logoLink to The AAPS Journal
. 2005 Sep 22;7(2):E288–E327. doi: 10.1208/aapsj070230

Fish drug analysis—Phish-pharm: A searchable database of pharmacokinetics data in fish

Renate Reimschuessel 1,✉, Leslie Stewart 2, Elizabeth Squibb 3, Keiko Hirokawa 4, Tiffany Brady 3, Deborah Brooks 5, Badar Shaikh 1, Clifford Hodsdon 6
PMCID: PMC2750967  PMID: 16353911

Abstract

Information about drug residues and pharmacokinetic parameters in aquatic species is relatively sparse. In addition, it is difficult to rapidly compare data between studies due to differences in experimental conditions, such as water temperatures and salinity. To facilitate the study of aquatic species drug metabolism, we constructed a Fish Drug/Chemical Analysis Phish-Pharm (FDA-PP) database. This database consists of more than 400 articles that include data from 90 species (64 genera) of fish. Data fields include genus, species, water temperatures, the average animal weight, sample types analyzed, drug (or chemical) name, dosage, route of administration, metabolites identified, method of analysis, protein binding, clearance, volume of distribution in a central compartment (Vc) or volume of distribution at steady-state (Vd), and drug half-lives (t1/2). Additional fields list the citation, authors, title, and Internet links. The document will be periodically updated, and users are invited to submit additional data. Updates will be announced in future issues ofThe AAPS Journal. This database will be a valuable resource to investigators of drug metabolism in aquatic species as well as government and private organizations involved in the drug approval process for aquatic species.

Keywords: aquatic, fish, drug, pharmacokinetics, residues, database, Web

Full Text

The Full Text of this article is available as a PDF (589.4 KB).

References

  • 1.Schnick RA, Gingerich WH, Griffin BR, Erdahl D. Progress of the Federal-State Aquaculture Drug Approval Partnership Project. American Fisheries Society Fish Health Newsletter. 2001;29:6–7. [Google Scholar]
  • 2.Haskell SR, Payne MA, Webb AI, Riviere JE, Craigmill AL. Current approved drugs for aquatic species. J Am Vet Med Assoc. 2004;224:50–51. doi: 10.2460/javma.2004.224.50. [DOI] [PubMed] [Google Scholar]
  • 3.National Aquaculture Association. National Aquaculture Association Web site. Available at: http://www.nationalaquaculture.org. Accessed September 21, 2005.
  • 4.FDA/CVM.CVM and aquaculture. Food and Drug Administration Web site. Available at: http://www.fda.gov/cvm/aqualibtoc.htm. Accessed September 21, 2005.
  • 5.Friedlander LG, Brynes SD, Fernandez AH. The human food safety evaluation of new animal drugs. Vet Clin North Am Food Anim Pract. 1999;15:1–11. doi: 10.1016/s0749-0720(15)30203-6. [DOI] [PubMed] [Google Scholar]
  • 6.The National Research Support Project No. 7. NRSP-7 minor use animal drug program. United States Dept of Agriculture, Cooperative State Research, Education and Extension Service. Available at: http://www. nrsp-7.org/. Accessed September 21, 2005.
  • 7.Schnick RA. Use of chemicals in fish management and fish culture: past and future. In: Smith DJ, Gingerich WH, Beconi-Barker MG, eds.Xenobiotics in Fish. New York, NY: Kluwer Academic/Plenum Publishers; 1999:1–14.
  • 8.Schnick RA. Aquaculture chemicals. In: Kirk-Othmer Encyclopedia of Chemical Technology-4th edition, Volume 3. New York, NY: John Wiley and Sons, Inc. 1992:608–623.
  • 9.American Veterinary Medical Association. Minor Use for Minor Species Animal Health Act. Available at: http://www.avma.org/scienact/mums/default.asp. Accessed September 21, 2005.
  • 10.FDA/CVM. Guidance 61-FDA Approval of New Animal Drugs for Minor Uses and for Minor Species. Food and Drug Administration Web site. Available at: http://www.fda.gov/cvm/guidance/minorgde.pdf. Accessed September 21, 2005.
  • 11.Gingerich WH, Stehly GR, Clark KJ, Hayton WL. Crop grouping: a proposal for public aquaculture. Vet Human Toxicol. 1998;40(suppl 2):24–31. [PubMed] [Google Scholar]
  • 12.MacMillan JR. Drug development for use by the aquaculture industry: the producers' perspective. Vet Hum Toxicol. 1998;40(suppl 2):7–9. [PubMed] [Google Scholar]
  • 13.Sundlof SF. Drug development for the aquaculture industry: a perspective from the Center for Veterinary Medicine. Vet Hum Toxicol. 1998;40(suppl 2):5–7. [PubMed] [Google Scholar]
  • 14.Craigmill AL, Cortright KA. Interspecies considerations in the evaluation of human food safety for veterinary drugs. AAPS Pharm Sci. 2002;4(4):E34–E34. doi: 10.1208/ps040434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.JSA. United States Joint Subcommittee on Aquaculture Web site. Available at: http://ag.ansc.purdue.edu/aquanic/jsa/ Accessed September 21, 2005.
  • 16.Schnick R. National Coordinator for Aquaculture New Animal Drug Applications Web site. Available at: http://ag.ansc.purdue.edu/aquanic/jsa/aquadrugs/. Accessed September 21, 2005.
  • 17.Jones J, Kinnel M, Christenson R, Reimschuessel R. Gentamicin concentrations in toadfish and goldfish Serum. J Aquat Anim Health. 1997;9:211–215. doi: 10.1577/1548-8667(1997)009<0211:CGCITA>2.3.CO;2. [DOI] [Google Scholar]
  • 18.Sohlberg S, Ingebrigtsen K, Hansen MK, Hayton WL, Horsberg TE. Flumequine in Atlantic salmonSalmo salar: disposition in fish held in sea water versus fresh water. Dis Aquat Organ. 2002;49:39–44. doi: 10.3354/dao049039. [DOI] [PubMed] [Google Scholar]
  • 19.Barron MG, Tarr BD, Hayton WL. Temperature dependence of Di-2-ethylhexyl phthalate (DEHP) pharmacokinetics in rainbow trout. Toxicol Appl Pharmacol. 1987;88:305–312. doi: 10.1016/0041-008X(87)90205-5. [DOI] [PubMed] [Google Scholar]
  • 20.Bjorklund H, Bylund G. Temperature-related absorption and excretion of oxytetracycline in rainbow trout (Salmo gairdneri R.) Aquaculture. 1990;84:363–361. doi: 10.1016/0044-8486(90)90101-R. [DOI] [Google Scholar]
  • 21.Ginneken VJTh, Nouws JFM, Grondel JL, Driessens F, Degen M. Pharmacokinetics of sulphadimidine in carp (Cyprinus carpio L.) and rainbow trout (Salmo gairdneri Richardson) acclimated at two different temperature levels. Vet Q. 1991;13(2):88–96. doi: 10.1080/01652176.1991.9694290. [DOI] [PubMed] [Google Scholar]
  • 22.Stehly GR, Meinertz JR, Gingerich WH. Effects of temperature on the elimination of benzocaine and acetylated benzocaine residues from the edible fillet of rainbow trout (Oncorhynchus mykiss) Food Addit Contam. 2000;17:387–392. doi: 10.1080/026520300404798. [DOI] [PubMed] [Google Scholar]
  • 23.Draft Guidance CDER. Estimating a safe starting dose in clinical trials for therapeutics in human volunteers. Food and Drug Administration Web site. Available at: http://www.fda.gov/cber/gdlns/dose.pdf. Accessed September 21, 2005.
  • 24.Mahmood I. Interspecies scaling: is a priori knowledge of cytochrome p450 isoenzymes involved in drug metabolism helpful in prediction of clearance in humans from animal data? Drug Metabol Drug Interact. 2001;18:135–147. doi: 10.1515/dmdi.2001.18.2.135. [DOI] [PubMed] [Google Scholar]
  • 25.Mahmood I. Interspecies scaling of protein drugs: prediction of clearance from animals to humans. J Pharm Sci. 2004;93:177–185. doi: 10.1002/jps.10531. [DOI] [PubMed] [Google Scholar]
  • 26.ASTDR. Agency for Toxic Substances and Disease Registry Web site. Available at: http://www.atsdr.cde.gov/.Accessed September 21, 2005.
  • 27.EPA—U.S. Environmental Protection Agency. Guidelines for Ecological Risk Assessment. Risk Assessment Forum, EPA/630/R095/002F, 1998. Available at: http://cfpub.epa.gov/ncea/cfm/recordisplay. cfm?deid-12460. Accessed September 21, 2005.
  • 28.Human Interindividual Variability in Parameters Related to Susceptibility for Toxic Effects [database online]. Clark University Database Web site. Available at: http://www.clarku.edu/faculty/dhattis/. Accessed September 21, 2005.
  • 29.Erhardt PW. A human drug metabolism database: potential roles in the quantitative predictions of drug metabolism and metabolism-related drug-drug interactions. Curr Drug Metab. 2003;4:411–422. doi: 10.2174/1389200033489299. [DOI] [PubMed] [Google Scholar]
  • 30.FARAD. Food Animal Residue Avoidance Databank Homepage. Available at: http://www.farad.org/. Accessed September 21, 2005.
  • 31.Keller F, Frankewitsch T, Zellner D, Simon S, Czock D, Giehl M. Standardized structure and modular design of a pharmacokinetic data-base. Comput Methods Programs Biomed. 1998;55:107–115. doi: 10.1016/S0169-2607(97)00061-8. [DOI] [PubMed] [Google Scholar]
  • 32.Yan Q, Sadee W. Human membrane transporter database: a Webaccessible relational database for drug transport studies and pharmacogenomics. AAPS Pharm Sci. 2000;2(3):E20–E20. doi: 10.1208/ps020320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Eeckhout NJ, Peteghem CH, Helbo VC, Maghuin-Rogister GC, Cornelis MR. New database on hormone and veterinary drug residue determination in animal products. Analyst. 1998;123:2423–2427. doi: 10.1039/a804941f. [DOI] [PubMed] [Google Scholar]
  • 34.Riviere JE, Martin-Jimenez T, Sundlof SF, Craigmill AL. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. J Vet Pharmacol Ther. 1997;20:453–463. doi: 10.1046/j.1365-2885.1997.00095.x. [DOI] [PubMed] [Google Scholar]
  • 35.Haskell SR, Gehring R, Payne MA, et al. Update on FARAD food animal drug withholding recommendations. J Am Vet Med Assoc. 2003;223:1277–1278. doi: 10.2460/javma.2003.223.1277. [DOI] [PubMed] [Google Scholar]
  • 36.FDA/CVM. CVM Guidance For Industry. Guidance No. 3, General Principles for Evaluating the Safety of Compounds Used in Food-Producing Animals. Revised July 1994. Available at: http://www.fda.gov/cvm/guidance/guideline3toc.html. Accessed September 21, 2005.
  • 37.Setzer MD. Pharmacokinetics of gentamicin in channel catfish (Ictalurus punctatus) Am J Vet Res. 1985;46:2558–2561. [PubMed] [Google Scholar]
  • 38.Stoskopf MK, Kennedy-Stoskopf S, Arnold J, Andrews J, Perlstein MT. Therapeutic aminoglycoside antibiotic levels in brown shark,Carcharhinus plumbeus (Nardo) J Fish Dis. 1986;9:303–311. doi: 10.1111/j.1365-2761.1986.tb01019.x. [DOI] [Google Scholar]

Articles from The AAPS Journal are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES